US 8450299
Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
granted A61KA61K31/56A61K31/567
Quick answer
US patent 8450299 (Methods of hormonal treatment utilizing ascending-dose extended cycle regimens) held by Teva Womans's Health, Inc. expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Teva Womans's Health, Inc.
- Grant date
- Tue May 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/56, A61K31/567, A61K31/57, A61P